MedImmune, the R&D arm of AstraZeneca has teamed up with California based 4DMT, a next-generation virus-based gene therapy research house developing a treatment for chronic lung disease
The pharmaceutical industry celebrated the 70th anniversary of the NHS by recognising the myriad contributions that the sector has made to the lives of many people.
AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the green-light for first-line use against additional types of non-small ce
